Navamedic ASA (NAVA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Navamedic ASA (NAVA) has a cash flow conversion efficiency ratio of 0.072x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr24.19 Million ≈ $2.55 Million USD) by net assets (Nkr334.08 Million ≈ $35.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Navamedic ASA - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Navamedic ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read NAVA current and long-term liabilities for a breakdown of total debt and financial obligations.
Navamedic ASA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Navamedic ASA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vection Technologies Ltd
AU:VR1
|
0.003x |
|
Pan Brothers Tbk
JK:PBRX
|
0.059x |
|
Fractal Gaming Group AB
ST:FRACTL
|
-0.074x |
|
Australian Vanadium Ltd
AU:AVL
|
-0.040x |
|
Union Corporation
KO:000910
|
0.034x |
|
Mawana Sugars Limited
NSE:MAWANASUG
|
0.961x |
|
Francotyp-Postalia Holding AG
F:FPH
|
0.005x |
|
Victory Square Technologies Inc
F:6F6
|
0.006x |
Annual Cash Flow Conversion Efficiency for Navamedic ASA (2003–2025)
The table below shows the annual cash flow conversion efficiency of Navamedic ASA from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see Navamedic ASA market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr334.08 Million ≈ $35.15 Million |
Nkr25.59 Million ≈ $2.69 Million |
0.077x | -53.21% |
| 2024-12-31 | Nkr240.44 Million ≈ $25.30 Million |
Nkr39.35 Million ≈ $4.14 Million |
0.164x | +1570.51% |
| 2023-12-31 | Nkr222.39 Million ≈ $23.40 Million |
Nkr2.18 Million ≈ $229.29K |
0.010x | -88.55% |
| 2022-12-31 | Nkr209.72 Million ≈ $22.07 Million |
Nkr17.94 Million ≈ $1.89 Million |
0.086x | +1095.23% |
| 2021-12-31 | Nkr151.24 Million ≈ $15.91 Million |
Nkr-1.30 Million ≈ $-136.80K |
-0.009x | +65.00% |
| 2020-12-31 | Nkr129.49 Million ≈ $13.63 Million |
Nkr-3.18 Million ≈ $-334.63K |
-0.025x | -115.29% |
| 2019-12-31 | Nkr79.23 Million ≈ $8.34 Million |
Nkr12.72 Million ≈ $1.34 Million |
0.161x | +144.27% |
| 2018-12-31 | Nkr99.32 Million ≈ $10.45 Million |
Nkr-36.02 Million ≈ $-3.79 Million |
-0.363x | -159.37% |
| 2017-12-31 | Nkr96.70 Million ≈ $10.18 Million |
Nkr59.07 Million ≈ $6.22 Million |
0.611x | +545.20% |
| 2016-12-31 | Nkr105.73 Million ≈ $11.13 Million |
Nkr-14.51 Million ≈ $-1.53 Million |
-0.137x | -171.72% |
| 2015-12-31 | Nkr118.28 Million ≈ $12.45 Million |
Nkr22.63 Million ≈ $2.38 Million |
0.191x | +297.98% |
| 2014-12-31 | Nkr111.23 Million ≈ $11.70 Million |
Nkr-10.75 Million ≈ $-1.13 Million |
-0.097x | +33.78% |
| 2013-12-31 | Nkr107.26 Million ≈ $11.29 Million |
Nkr-15.65 Million ≈ $-1.65 Million |
-0.146x | -117.92% |
| 2012-12-31 | Nkr96.68 Million ≈ $10.17 Million |
Nkr-6.47 Million ≈ $-681.19K |
-0.067x | -6435.86% |
| 2011-12-31 | Nkr93.24 Million ≈ $9.81 Million |
Nkr-95.52K ≈ $-10.05K |
-0.001x | +99.24% |
| 2010-12-31 | Nkr100.21 Million ≈ $10.54 Million |
Nkr-13.46 Million ≈ $-1.42 Million |
-0.134x | -811.95% |
| 2009-12-31 | Nkr111.78 Million ≈ $11.76 Million |
Nkr-1.65 Million ≈ $-173.31K |
-0.015x | +84.76% |
| 2008-12-31 | Nkr110.24 Million ≈ $11.60 Million |
Nkr-10.66 Million ≈ $-1.12 Million |
-0.097x | -324.44% |
| 2007-12-31 | Nkr128.99 Million ≈ $13.57 Million |
Nkr5.56 Million ≈ $584.83K |
0.043x | +124.42% |
| 2006-12-31 | Nkr60.87 Million ≈ $6.40 Million |
Nkr-10.74 Million ≈ $-1.13 Million |
-0.176x | -144.73% |
| 2005-12-31 | Nkr43.19 Million ≈ $4.54 Million |
Nkr-3.11 Million ≈ $-327.70K |
-0.072x | +62.10% |
| 2004-12-31 | Nkr19.03 Million ≈ $2.00 Million |
Nkr-3.62 Million ≈ $-381.04K |
-0.190x | +68.79% |
| 2003-12-31 | Nkr7.21 Million ≈ $758.70K |
Nkr-4.40 Million ≈ $-462.53K |
-0.610x | -- |
About Navamedic ASA
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutritio… Read more